Isoflavonas de soya y evidencias sobre la protección cardiovascular

作者: Samuel Durán Agüero , Natalia González Cañete

DOI: 10.3305/NH.2014.29.6.7047

关键词:

摘要: Soya isoflavones represent a group of non-nutritive, bioactive compounds, non-steroidal phenolic nature that are present in soy bean and derived foods. They share with other compounds the capacity binding to estrogenic receptors from different cells tissues so they may act as phytoestrogens. The current interest these comes knowledge Asian populations high levels their consumption prevalence cancer cardiovascular disease is lower, compared Western countries populations. This benefit would be result not only modulation plasma lipids, which widely studied mechanism. paper reviews published evidence about beneficial effects soya mechanisms action health surpass traditionally approached such implicate regulation cellular enzymatic functions situations inflammation, thrombosis, atherosclerotic progression.

参考文章(126)
Kenneth D. R. Setchell, Nadine M. Brown, Pankaj Desai, Linda Zimmer-Nechemias, Brian E. Wolfe, Wayne T. Brashear, Abby S. Kirschner, Aedin Cassidy, James E. Heubi, Bioavailability of Pure Isoflavones in Healthy Humans and Analysis of Commercial Soy Isoflavone Supplements Journal of Nutrition. ,vol. 131, ,(2001) , 10.1093/JN/131.4.1362S
Xia Xu, Huei-Ju Wang, Patricia A. Murphy, Suzanne Hendrich, Neither Background Diet Nor Type of Soy Food Affects Short-Term Isoflavone Bioavailability in Women Journal of Nutrition. ,vol. 130, pp. 798- 801 ,(2000) , 10.1093/JN/130.4.798
Escobar F. María Cristina, Prevención del riesgo cardiovascular: políticas chilenas Revista Médica Clínica Las Condes. ,vol. 23, pp. 651- 655 ,(2012) , 10.1016/S0716-8640(12)70364-4
Muchtaruddin Mansyur, Adi Hidajat, Fransiscus D Suyatna, Pusparini, Rahayuningsih Dharma, Effect of Soy Isoflavone Supplementation on Vascular Endothelial Function and Oxidative Stress in Postmenopausal Women: a Community Randomized Controlled Trial Asia Pacific Journal of Clinical Nutrition. ,vol. 22, pp. 357- 364 ,(2013) , 10.6133/APJCN.2013.22.3.13
P.H.M. Peeters, L. Keinan-Boker, Y.T. van der Schouw, D.E. Grobbee, Phytoestrogens and Breast Cancer Risk Breast Cancer Research and Treatment. ,vol. 77, pp. 171- 183 ,(2003) , 10.1023/A:1021381101632
Helen Wiseman, James D O'Reilly, Herman Adlercreutz, Anthony I Mallet, Elizabeth A Bowey, Ian R Rowland, Thomas AB Sanders, Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans The American Journal of Clinical Nutrition. ,vol. 72, pp. 395- 400 ,(2000) , 10.1093/AJCN/72.2.395
Kenneth D. R. Setchell, Nadine M. Brown, Eva Lydeking-Olsen, The Clinical Importance of the Metabolite Equol—A Clue to the Effectiveness of Soy and Its Isoflavones Journal of Nutrition. ,vol. 132, pp. 3577- 3584 ,(2002) , 10.1093/JN/132.12.3577
Andreas Kampkötter, Yvonni Chovolou, Andreas Kulawik, Elke Röhrdanz, Nadine Weber, Peter Proksch, Wim Wätjen, Isoflavone daidzein possesses no antioxidant activities in cell-free assays but induces the antioxidant enzyme catalase Nutrition Research. ,vol. 28, pp. 620- 628 ,(2008) , 10.1016/J.NUTRES.2008.06.002
Herman Adlercreutz, Phyto-oestrogens and cancer. Lancet Oncology. ,vol. 3, pp. 364- 373 ,(2002) , 10.1016/S1470-2045(02)00777-5